Renal Cell Carcinoma News and Research

Latest Renal Cell Carcinoma News and Research

Circulating tumor cells in the bone marrow of  patients with metastatic renal cell carcinoma may be prognostic of outcome

Circulating tumor cells in the bone marrow of patients with metastatic renal cell carcinoma may be prognostic of outcome

Underutilization of partial nephrectomy for localized renal cell carcinoma in the U.S.

Underutilization of partial nephrectomy for localized renal cell carcinoma in the U.S.

Thrombocytosis: A clinical marker of tumor aggressiveness in renal cell carcinoma

Thrombocytosis: A clinical marker of tumor aggressiveness in renal cell carcinoma

Therapy for metastatic renal cell carcinoma remains inadequate

Therapy for metastatic renal cell carcinoma remains inadequate

Is there any role for thalidomide as a monotherapy in the management of metastatic renal cell carcinoma?

Is there any role for thalidomide as a monotherapy in the management of metastatic renal cell carcinoma?

Targeted cancer therapies: Another step forward

Targeted cancer therapies: Another step forward

Targeted cancer therapies: Another step forward

Targeted cancer therapies: Another step forward

Imatinib mesylate (Gleevec) may not be effective at treating kidney cancer

Imatinib mesylate (Gleevec) may not be effective at treating kidney cancer

FDA approval sought for Pfizer's new cancer drug

FDA approval sought for Pfizer's new cancer drug

Radiofrequency ablation (RFA) is an effective, longlasting treatment for small kidney tumors in selected patients

Radiofrequency ablation (RFA) is an effective, longlasting treatment for small kidney tumors in selected patients

New anticancer drug SU11248 shows continued response for patients with late-stage kidney cancer

New anticancer drug SU11248 shows continued response for patients with late-stage kidney cancer

Avastin available across Europe within the next few weeks

Avastin available across Europe within the next few weeks

Evaluation of BAY 43-9006 (Sorafenib) for pancreatic cancer

Evaluation of BAY 43-9006 (Sorafenib) for pancreatic cancer

Key molecule helps identify renal cell carcinoma

Key molecule helps identify renal cell carcinoma

Lorus Therapeutics allowed Canadian patent to protect anticancer drugs

Lorus Therapeutics allowed Canadian patent to protect anticancer drugs

Counseling for breast cancer patients means healthier diets, reduced smoking and stronger immune systems

Counseling for breast cancer patients means healthier diets, reduced smoking and stronger immune systems

FDA fast tracks temsirolimus, first-line treatment of poor-prognosis patients with advanced renal cell carcinoma

FDA fast tracks temsirolimus, first-line treatment of poor-prognosis patients with advanced renal cell carcinoma

Potential new strategy for blocking tumor growth

Potential new strategy for blocking tumor growth

Drug Tarceva improves survival chance for patients with advanced lung cancer

Drug Tarceva improves survival chance for patients with advanced lung cancer

Avastin study shows significant improvement in patients with metastatic colorectal cancer

Avastin study shows significant improvement in patients with metastatic colorectal cancer